Aspergillosis clinical trials at UCSF

1 in progress, 0 open to eligible people

Olorofim Aspergillus Infection Study
Sorry, in progress, not accepting new patients
The purpose of this study is to compare treatment with olorofim versus treatment with AmBisome® followed by standard of care (SOC) in patients with IFD caused by proven IA or probable lower respiratory tract disease Aspergillus species (invasive aspergillosis, IA).
San Francisco, California and other locations

Last updated: January 4, 2026